Cargando…
Large inoperable leiomyosarcoma of the prostate: treated by transcatheter arterial chemoembolization with drug-eluting microspheres
BACKGROUND: Prostatic leiomyosarcoma (LMS) has a poor prognosis with a median overall survival (OS) of 15–18 months. For patients with metastatic disease, radical surgical resection, with or without adjuvant systemic chemotherapy and radiation therapy, unfortunately provides limited therapeutic bene...
Autores principales: | Wang, Mao Qiang, Zhang, Jin Long, Yuan, Kai, Yuan, Bing, Duan, Feng, Yan, Jie Yu, Wang, Yan, Fu, Jin Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238308/ https://www.ncbi.nlm.nih.gov/pubmed/32489428 http://dx.doi.org/10.1177/1758835920917573 |
Ejemplares similares
-
Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma
por: Nouri, Yasir M., et al.
Publicado: (2019) -
Development and evaluation of polyacrylamide microspheres loaded with phloretin and tantalum for transcatheter arterial embolization
por: Li, Liang, et al.
Publicado: (2023) -
Incidentally Detected Inoperable Malignant Pheochromocytoma with Hepatic Metastasis Treated by Transcatheter Arterial Chemoembolization
por: Kim, Joong Keun, et al.
Publicado: (2014) -
Combination therapy of transcatheter arterial chemoembolization with axitinib for the treatment of inoperable hepatocellular carcinoma
por: Nouso, Kazuhiro, et al.
Publicado: (2020) -
Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma
por: de Lima Araujo, Luiz Henrique, et al.
Publicado: (2013)